首页|中国基层医疗机构基础胰岛素的使用现状和选择的新思路

中国基层医疗机构基础胰岛素的使用现状和选择的新思路

扫码查看
近年来,国家越来越重视基层医疗机构的服务质量,但是目前糖尿病的基层医疗现状并不令人十分满意。这与我国基层医疗机构的医护人员对基础胰岛素的认识不足有一定关系。本文从基础胰岛素在中国基层医疗机构的应用现状、使用障碍原因分析入手,重点比较基础胰岛素类似物(包括德谷胰岛素与甘精胰岛素)的有效性和安全性。结合近几年胰岛素集中采购的介绍,希望本文为中国基层医疗机构的基础胰岛素选择提供新的思路,从而更好地改善中国基层医疗机构的血糖控制。
Current Situation and Solutions of Basal Insulin Use in Primary Healthcare Institution in China
In recent years,the country has paid close attention to the service quality of primary medical institutions,but the current situation of basic primary care for diabetes is not satisfactory.This is related to the insufficient understanding of basic insulin in primary healthcare in China.This review starts with the current application status of basal insulin in primary medical institutions in China and the analysis of the reasons for its applicable plight,with a focus on comparing the effectiveness and safety of basal insulin analogues(including insulin degludec and insulin glargine).Based on the introduction of volume-based insulin procurement in recent years,it is hoped that the review will help to rationally select basal insulin and improve blood glucose control in primary medical institutions in China.

Basal insulinDegludecGlarginePrimary healthcare institution

谷伟军

展开 >

解放军总医院第一医学中心,北京 100853

基础胰岛素 德谷胰岛素 甘精胰岛素 基层医疗

2024

药品评价
江西省药学会

药品评价

影响因子:0.672
ISSN:1672-2809
年,卷(期):2024.21(1)
  • 35